June 4, 2021 10:48 AM EDT
News Briefing

Fate sees pos­i­tive B-cell lym­phoma da­ta at #AS­CO21; Imag­inAb se­cures fund­ing for CD8 imag­ing tri­als

Max Gelman

Senior Editor

Josh Sullivan

Fate Ther­a­peu­tics re­vealed some new da­ta at #AS­CO21 for their R/R B-cell lym­phoma pro­gram on Fri­day.

The San Diego biotech

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Lil­ly drops body mass ranges from FDA la­bel for weight loss drug

GSK ter­mi­nates Phase 2 tri­al of HBV ther­a­peu­tic vac­cine

Co­herus makes fi­nal, $483M piv­ot away from biosim­i­lars

Ipsen se­cures rights to pre­clin­i­cal T cell en­gager in $610M pact with French biotech

Janux soars on ear­ly prostate can­cer da­ta that could chal­lenge No­var­tis' Plu­vic­to

Roche teams up with Chica­go au­toim­mune biotech COUR Phar­ma­ceu­ti­cals

A service from the Financial Times